Nippon India Pharma Fund Overview
Category Pharma Fund
BMSMONEY Rank -
BMSMONEY Rating
Gro. Opt. As On: 20-01-2025
NAV ₹499.68(R) +0.26% ₹554.08(D) +0.27%
Returns 1Y 3Y 5Y 7Y 10Y
LumpSum (R) 22.78% 19.13% 26.17% 19.25% 14.51%
LumpSum (D) 23.89% 20.21% 27.32% 20.31% 15.53%
SIP (R) -17.05% 24.58% 22.17% 22.35% 18.51%
SIP (D) -16.21% 25.74% 23.29% 23.45% 19.52%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
0.76 0.4 0.71 1.56% 0.13
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
15.07% -14.68% -16.6% 0.89 10.32%
Top Pharma Fund
Fund Name Rank Rating
Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
Sbi Healthcare Opportunities Fund -
Tata India Pharma & Healthcare Fund -
Uti Healthcare Fund -
- -

NAV Date: 20-01-2025

Scheme Name NAV Rupee Change Percent Change
NIPPON INDIA PHARMA FUND - IDCW Option 127.22
0.3300
0.2600%
NIPPON INDIA PHARMA FUND - DIRECT Plan - IDCW Option 177.59
0.4700
0.2700%
Nippon India Pharma Fund-Growth Plan-Growth Option 499.68
1.2900
0.2600%
Nippon India Pharma Fund-Growth Plan-Bonus Option 499.68
1.2900
0.2600%
Nippon India Pharma Fund - Direct Plan Growth Plan - Bonus Option 554.08
1.4700
0.2700%
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option 554.08
1.4700
0.2700%

Review Date: 20-01-2025

A review of the different performance parameters of the fund is as follows:
  1. Returns: It signifies the growth in the investment's value over a specific period, presented either as a percentage or a monetary figure. Our analysis focused on six return parameters of this fund. The return parameters have been categorized into three performance groups: the top 25%, those below the top 25% but above average, and those below average. Now, let's take a look at how each parameter has performed.
    1. Top 25%: The fund does not have any return parameter in the top 25% in the category.
    2. Above Average Below the Top 25%: The fund does not have any return parameter which is above average but below the top 25%.
    3. Below Average: Nippon India Pharma Fund has six return parameters that are below average in the category, which are listed below:
      • 5Y Return %
      • 1Y Return %
      • 3Y Return %
      • 6M Return %
      • 1M Return %
      • 3M Return %
  2. Risk: Various factors can lead to the risk of either not meeting expected returns or encountering a monetary loss. For Nippon India Pharma Fund, we have analyzed two risk parameters and divided them into three groups the lowest 25%, below average but above the lowest 25%, and above average, which are described below.
    1. Lowest 25%: Nippon India Pharma Fund does not have any risk parameters in the lowest 25% of the category. It means high risk compared to other funds in the category.
    2. Below Average but Above the Lowest 25%: Nippon India Pharma Fund has two risk parameters that are below average but above the lowest 25% in the category. These are:
      • Standard Deviation: It is a measure of the dispersion of a set of data from its mean. It is calculated as the square root of variance by determining the variation between each data point relative to the mean. The higher the standard deviation, the greater the risk. The standard deviation of the fund is 15.07 %.
      • Semi-Deviation: It is a measure of the dispersion of a set of data from its mean. It is calculated as the square root of variance by determining the variation between each data point relative to the mean. The higher the semi-deviation, the greater the risk. The semi-deviation of the fund is 10.32 %.
    3. Above Average: Nippon India Pharma Fund does not have any risk parameters above average; which is a good sign.
  3. Risk Adjusted Performance Parameters: In mutual funds, risk-adjusted performance parameters are evaluation tools that gauge the returns of an investment against the risk taken. They assist investors in comparing various investments, factoring in both risk and returns. We have evaluated four risk-adjusted performance parameters of the fund.
    1. Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the top 25% of the category.
    2. Above Average Below Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.
    3. Below Average Risk Adjusted Performance Parameters: Nippon India Pharma Fund has four risk-adjusted performance parameters of the fund that are below average in the category.
      • Sharpe Ratio: Nippon India Pharma Fund has a Sharpe Ratio of 0.76 compared to the category average of 0.84.
      • Sterling Ratio: Nippon India Pharma Fund has a Sterling Ratio of 0.71 compared to the category average of 0.78.
      • Sortino Ratio: Nippon India Pharma Fund has a Sortino Ratio of 0.4 compared to the category average of 0.46.
      • Treynor Ratio: Nippon India Pharma Fund has a Treynor Ratio of 0.13 compared to the category average of 0.14.


Not able to see in mobile!!! save the chart by clicking on camera icon.

KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -2.59
-1.74
-2.69 | -0.23 11 | 12 Poor
3M Return % -3.68
-2.05
-8.37 | 1.62 10 | 12 Poor
6M Return % 7.63
11.49
-0.84 | 19.71 10 | 12 Poor
1Y Return % 22.78
29.29
17.54 | 39.35 9 | 11 Average
3Y Return % 19.13
20.24
17.50 | 23.80 5 | 7 Average
5Y Return % 26.17
26.28
22.35 | 28.97 4 | 7 Good
7Y Return % 19.25
18.31
17.34 | 19.25 1 | 4 Very Good
10Y Return % 14.51
13.39
12.49 | 14.51 1 | 3 Very Good
15Y Return % 17.60
17.08
15.91 | 17.74 2 | 3 Good
1Y SIP Return % -17.05
-12.07
-23.57 | -1.40 9 | 11 Average
3Y SIP Return % 24.58
27.20
23.99 | 32.29 6 | 7 Average
5Y SIP Return % 22.17
23.37
20.34 | 26.71 6 | 7 Average
7Y SIP Return % 22.35
22.94
22.35 | 24.08 4 | 4 Poor
10Y SIP Return % 18.51
17.99
17.43 | 18.51 1 | 3 Very Good
15Y SIP Return % 17.85
17.19
16.03 | 17.85 1 | 3 Very Good
Standard Deviation 15.07
15.28
14.18 | 16.03 3 | 8 Good
Semi Deviation 10.32
10.39
10.01 | 10.81 3 | 8 Good
Max Drawdown % -16.60
-16.33
-18.46 | -14.07 4 | 8 Good
VaR 1 Y % -14.68
-16.75
-18.96 | -14.68 1 | 8 Very Good
Average Drawdown % -5.64
-5.31
-6.71 | -4.20 6 | 8 Average
Sharpe Ratio 0.76
0.84
0.64 | 1.10 6 | 8 Average
Sterling Ratio 0.71
0.78
0.66 | 1.01 6 | 8 Average
Sortino Ratio 0.40
0.46
0.36 | 0.64 6 | 8 Average
Jensen Alpha % 1.56
2.90
-0.76 | 7.18 6 | 8 Average
Treynor Ratio 0.13
0.14
0.11 | 0.19 6 | 8 Average
Modigliani Square Measure % 20.65
21.99
18.25 | 26.72 6 | 8 Average
Alpha % -0.13
1.16
-1.64 | 5.07 6 | 8 Average
Return data last Updated On : Jan. 20, 2025.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Dec. 31, 2024
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -2.52 -1.63 -2.59 | -0.09 11 | 12
3M Return % -3.47 -1.73 -7.99 | 2.06 10 | 12
6M Return % 8.11 12.22 -0.01 | 20.73 10 | 12
1Y Return % 23.89 30.94 19.49 | 41.11 10 | 11
3Y Return % 20.21 21.67 19.18 | 24.90 5 | 7
5Y Return % 27.32 27.83 24.23 | 30.21 5 | 7
7Y Return % 20.31 19.66 18.54 | 20.53 2 | 4
10Y Return % 15.53 14.54 13.61 | 15.53 1 | 3
1Y SIP Return % -16.21 -10.83 -22.11 | -0.03 9 | 11
3Y SIP Return % 25.74 28.73 25.74 | 33.48 7 | 7
5Y SIP Return % 23.29 24.85 22.08 | 27.84 6 | 7
7Y SIP Return % 23.45 24.31 23.45 | 25.39 4 | 4
10Y SIP Return % 19.52 19.09 18.54 | 19.52 1 | 3
Standard Deviation 15.07 15.28 14.18 | 16.03 3 | 8
Semi Deviation 10.32 10.39 10.01 | 10.81 3 | 8
Max Drawdown % -16.60 -16.33 -18.46 | -14.07 4 | 8
VaR 1 Y % -14.68 -16.75 -18.96 | -14.68 1 | 8
Average Drawdown % -5.64 -5.31 -6.71 | -4.20 6 | 8
Sharpe Ratio 0.76 0.84 0.64 | 1.10 6 | 8
Sterling Ratio 0.71 0.78 0.66 | 1.01 6 | 8
Sortino Ratio 0.40 0.46 0.36 | 0.64 6 | 8
Jensen Alpha % 1.56 2.90 -0.76 | 7.18 6 | 8
Treynor Ratio 0.13 0.14 0.11 | 0.19 6 | 8
Modigliani Square Measure % 20.65 21.99 18.25 | 26.72 6 | 8
Alpha % -0.13 1.16 -1.64 | 5.07 6 | 8
Return data last Updated On : Jan. 20, 2025.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Dec. 31, 2024
KPIs: Key Performance Indicators

Investment Period Regular Direct
Return % Current Value of ₹ 10000 Return % Current Value of ₹ 10000
1D 0.26 ₹ 10,026.00 0.27 ₹ 10,027.00
1W 0.09 ₹ 10,009.00 0.10 ₹ 10,010.00
1M -2.59 ₹ 9,741.00 -2.52 ₹ 9,748.00
3M -3.68 ₹ 9,632.00 -3.47 ₹ 9,653.00
6M 7.63 ₹ 10,763.00 8.11 ₹ 10,811.00
1Y 22.78 ₹ 12,278.00 23.89 ₹ 12,389.00
3Y 19.13 ₹ 16,908.00 20.21 ₹ 17,369.00
5Y 26.17 ₹ 31,969.00 27.32 ₹ 33,453.00
7Y 19.25 ₹ 34,299.00 20.31 ₹ 36,494.00
10Y 14.51 ₹ 38,774.00 15.53 ₹ 42,366.00
15Y 17.60 ₹ 113,809.00 ₹

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.

Investment Period Invested Amount Regular Direct
XIRR % Current Value of Invested Amount XIRR % Current Value of Invested Amount
1Y ₹ 12000 -17.05 ₹ 10,858.73 -16.21 ₹ 10,916.59
3Y ₹ 36000 24.58 ₹ 51,472.98 25.74 ₹ 52,294.82
5Y ₹ 60000 22.17 ₹ 104,106.42 23.29 ₹ 106,960.56
7Y ₹ 84000 22.35 ₹ 186,389.03 23.45 ₹ 193,803.96
10Y ₹ 120000 18.51 ₹ 318,104.16 19.52 ₹ 335,916.84
15Y ₹ 180000 17.85 ₹ 791,973.36 ₹


Date Nippon India Pharma Fund NAV Regular Growth Nippon India Pharma Fund NAV Direct Growth
20-01-2025 499.6813 554.0828
17-01-2025 498.3963 552.6175
16-01-2025 497.2792 551.3654
15-01-2025 497.8514 551.9863
14-01-2025 501.5534 556.0773
13-01-2025 499.2517 553.5119
10-01-2025 511.6379 567.2027
09-01-2025 521.2501 577.8447
08-01-2025 524.1705 581.068
07-01-2025 529.7757 587.2674
06-01-2025 525.3305 582.3255
03-01-2025 527.311 584.4781
02-01-2025 530.5674 588.0732
01-01-2025 529.3726 586.7347
31-12-2024 527.0907 584.1912
30-12-2024 524.9617 581.8174
27-12-2024 520.1167 576.4055
26-12-2024 515.5879 571.3726
24-12-2024 512.8464 568.3068
23-12-2024 513.9931 569.5635
20-12-2024 512.9617 568.3789

Fund Launch Date: 10/May/2004
Fund Category: Pharma Fund
Investment Objective: The Fund seeks to invest in pharma sector with focus on important segments of the sector viz Domestic Business, International & CRAMS and include deep value as well as high growth pharma businesses. The fund invests across market capitalization within the sector. It may suit investment horizon of around 2-3 years
Fund Description: An open ended equity scheme investing in pharma sector
Fund Benchmark: S&P BSE Healthcare TR
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.